Track Amoy Diagnostics , Ltd.'s receivables ($640M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), 300685.SZ shows a receivables of $640M. That compares with $620M in the prior-year period — up 3.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 300685.SZ's receivables is now $640M (was $620M) — a 3.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Amoy Diagnostics , Ltd. is outperforming or lagging.
Tracking 300685.SZ's receivables over time shows whether Amoy Diagnostics , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $640M That compares with $620M in the prior-year period — up 3.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Amoy Diagnostics , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $640M) with ownership activity and broader fundamentals.